Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bard

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Progress in Clinical and Biological Research|January 1, 1988
Effect of fenofibrate on apolipoprotein B containing lipoprotein particlesJ C Fruchart, J M Bard, C Fievet, et al.
Metabolism: Clinical and Experimental|November 1, 1995
Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein compositionJ M Bard, J Dallongeville, E Hagen, et al.
Clinical Chemistry|February 1, 1991
Heterozygous hypobetalipoproteinemia with fasting chylomicronemiaG Huet, M C Dieu, A Martin, et al.
The American Journal of Cardiology|July 13, 1995
Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study GroupJ M Bard, L Ose, E Hagen, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1993
Parental history of early myocardial infarction is associated with decreased levels of lipoparticle AI in adolescentsP Amouyel, D Isorez, J M Bard, et al.
Atherosclerosis|September 22, 2000
The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study)G Luc, J M Bard, A Evans, et al.
Biochimica Et Biophysica Acta|March 12, 1991
Isolation and characterization of human Lp-B lipoprotein containing apolipoprotein B as the sole apolipoproteinJ M Bard, L Candelier, G Agnani, et al.
Annales De Biologie Clinique|August 30, 2008
[PPAR alpha-L162V, frequency and relationship with type 2 diabetes among black Senegalese people]P Lopez-Sall, J M Bard, H Nazih, et al.
Metabolism: Clinical and Experimental|June 9, 2001
Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemiaR Frénais, C Maugeais, K Ouguerram, et al.
Circulation|May 1, 1994
Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS Study. European Atherosclerosis Research StudyM Rosseneu, J C Fruchart, J M Bard, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Progress in Clinical and Biological Research|January 1, 1988
Effect of fenofibrate on apolipoprotein B containing lipoprotein particlesJ C Fruchart, J M Bard, C Fievet, et al.
Metabolism: Clinical and Experimental|November 1, 1995
Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein compositionJ M Bard, J Dallongeville, E Hagen, et al.
Clinical Chemistry|February 1, 1991
Heterozygous hypobetalipoproteinemia with fasting chylomicronemiaG Huet, M C Dieu, A Martin, et al.
The American Journal of Cardiology|July 13, 1995
Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study GroupJ M Bard, L Ose, E Hagen, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1993
Parental history of early myocardial infarction is associated with decreased levels of lipoparticle AI in adolescentsP Amouyel, D Isorez, J M Bard, et al.
Atherosclerosis|September 22, 2000
The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study)G Luc, J M Bard, A Evans, et al.
Biochimica Et Biophysica Acta|March 12, 1991
Isolation and characterization of human Lp-B lipoprotein containing apolipoprotein B as the sole apolipoproteinJ M Bard, L Candelier, G Agnani, et al.
Annales De Biologie Clinique|August 30, 2008
[PPAR alpha-L162V, frequency and relationship with type 2 diabetes among black Senegalese people]P Lopez-Sall, J M Bard, H Nazih, et al.
Metabolism: Clinical and Experimental|June 9, 2001
Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemiaR Frénais, C Maugeais, K Ouguerram, et al.
Circulation|May 1, 1994
Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS Study. European Atherosclerosis Research StudyM Rosseneu, J C Fruchart, J M Bard, et al.
Pageof 11